Equels Thomas K 4
4 · AIM ImmunoTech Inc. · Filed Mar 27, 2024
Insider Transaction Report
Form 4
Equels Thomas K
CEO & President
Transactions
- Award
Options
2023-11-30+300,000→ 300,000 totalExercise: $0.47From: 2024-11-30Exp: 2033-11-30→ Common Stock (300,000 underlying)